Navignostics - About the company
Navignostics is a seed company based in Zurich (Switzerland), founded in 2022 by Stephane Chevrier, Bernd Bodenmiller and Jana Fischer. It operates as a Developer of personalized diagnostics for cancer patients. Navignostics has raised $7.65M in funding from Bruker and University of Zurich. The company has 397 active competitors, including 134 funded and 86 that have exited. Its top competitors include companies like Geneoscopy, 4baseCare and Intellia Therapeutics.
Company Details
Developer of personalized diagnostics for cancer patients. The company is developing diagnostic tests to develop treatments for several tumor indications. The company's products include novel spatial biomarker tests for patients with metastatic colorectal cancer.
- Website
- www.navignostics.com/
- Email ID
- *****@navignostics.com
- Phone Number
- +41 **********
Key Metrics
Founded Year
2022
Location
Zurich, Switzerland
Stage
Seed
Total Funding
$7.65M in 1 round
Latest Funding Round
Ranked
130th among 397 active competitors
Employee Count
17 as on Jul 31, 2026
Similar Companies
Sign up to download Navignostics' company profile
Navignostics's funding and investors
Navignostics has raised a total funding of $7.65M over 1 round. Its latest funding round was a Seed round on Sep 02, 2022 for $*****. 4 investors participated in its latest round. Navignostics has 4 institutional investors.
Here is the list of recent funding rounds of Navignostics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 02, 2022 | 5359997 | Seed | 7120739 | 8090928 | 8094948 | 5922579 |
Access funding benchmarks and valuations. Sign up today!View details of Navignostics's funding rounds and investors
Navignostics' founders and board of directors
Founder? Claim ProfileHere are the details of Navignostics' key team members:
- Stephane Chevrier: Co-Founder of Navignostics.
- Bernd Bodenmiller: Co-Founder of Navignostics.
- Jana Fischer: Co-Founder of Navignostics.
View details of Navignostics's Founder profiles and Board Members
Navignostics' employee count trend
Navignostics has 17 employees as of Jul 26. Here is Navignostics's employee count trend over the years:
Uncover Navignostics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Navignostics's Competitors and alternates
Top competitors of Navignostics include Geneoscopy, 4baseCare and Intellia Therapeutics. Here is the list of Top 10 competitors of Navignostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Geneoscopy 2015, St. Louis (United States), Series C | Developer of non-invasive biomarker tests for colorectal cancer | $219M | 67/100 | |
2nd | Provider of precision oncology solutions, including genomic testing and digital health | $25.9M | 67/100 | ||
3rd | Intellia Therapeutics 2014, Cambridge (United States), Public | Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases | $85M | 66/100 | |
4th | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 66/100 | |
5th | NeoGenomics 2002, Fort Myers (United States), Public | Provider of cancer genetic diagnostic services | - | 63/100 | |
6th |  UniQure 1998, Amsterdam (Netherlands), Public | Developer of gene-based therapies for patients with genetic or acquired diseases | $111M | 62/100 | |
7th |  Deep Genomics 2014, Toronto (Canada), Series C | AI-powered platform for RNA biology to accelerate genetic therapy discovery | $238M | 62/100 | |
8th | Personalis 2011, Menlo Park (United States), Public | Provider of genomic sequencing and diagnosis software for the healthcare industry | $87.3M | 61/100 | |
9th | Exicure 2009, Skokie (United States), Public | developer of gene silencing & immunomodulatory drugs using spherical nucleic acid (SNA) technology | $72.3M | 61/100 | |
10th | GenSight Biologics 2011, Paris (France), Public | Developer of viral vector-based gene therapies for retinal neurodegenerative diseases | $76.6M | 61/100 | |
130th |  Navignostics 2022, Zurich (Switzerland), Seed | Developer of personalized diagnostics for cancer patients | $7.65M | 38/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Navignostics's competitors? Click here to see the top ones
Navignostics's Investments and acquisitions
Navignostics has made no investments or acquisitions yet.
Reports related to Navignostics
Here is the latest report on Navignostics's sector:
News related to Navignostics
•
•
•
Precision Oncology Dx Firm Navignostics Raises CHF 7.5 M in Seed Funding From Bruker, Others360Dx•Nov 10, 2022•Navignostics, Bruker, Think.Health, Ventura Biomed and 1 other
•
Navignostics Selects Celegence's CAPTIS™ Technology Solution to Support IVDR CompliancePR Newswire•Oct 20, 2022•Navignostics, Celegence
•
UZH Life Science Fund invests in NavignosticsStartupticker•Sep 02, 2022•University of Zurich, Navignostics
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Navignostics
Explore our recently published companies
- Aishwarya Ear and Nose Piercing - Hyderabad based, Unfunded company
- One Tapp - Bengaluru based, Unfunded company
- BGF (Baugenossenschaft Frohheim) - Switzerland based, 1943 founded, Unfunded company
- Beazys Bundtz - United States based, Unfunded company
- C Production Dance Studio - Japan based, 2022 founded, Unfunded company
- CASCARA SOCIETY - Switzerland based, 2020 founded, Unfunded company
